Recently, whole-exome sequencing on CD34+ cells from PMF patients identified a recurrent mutation in complement factor I in 20% of patients, suggesting a role of the complement cascade in the MPN pathogenesis [98]. Here, CD34 is linked to myeloproliferative neoplasm.